BioMed Research International / 2013 / Article / Tab 4

Research Article

Role of the Promoter Polymorphism IL-6 −174G/C in Dermatomyositis and Systemic Lupus Erythematosus

Table 4

Comparison between the genotypes and ACR criteria.

GenotypeGG ( )GC ( )CC ( ) value

Malar rash20 (69.0%)5 (38.5%)9 (90.0%)NS*
Discoid rash6 (20.7%)3 (23.1%)0 (0.0%)NS
Photosensitivity17 (58.6%)8 (61.5%)5 (50.0%)NS
Oral ulcer1 (3.4%)2 (15.4%)0 (0.0%)NS
Arthritis18 (56.5%)9 (69.2%)7 (70.0%)NS
Serositis6 (20.7%)4 (30.8%)1 (10.0%)NS
Renal disease29 (100.0%)13 (100.0%)10 (100.0%)
Neurological disease6 (26.1%)2 (15.4%)2 (20.0%)NS
Haematological disease11 (37.9%)4 (30.8%)5 (50.0%)NS
Immunological disease (anti-dsDNA, anti-Sm, and antiphospholipid Ab)20 (69.0%)
6 (46.2%)
6 (60.0%)
NS
ANA22 (75.9%)7 (53.8%)7 (70.0%)NS

Not significant.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.